First-in-human trial assessing the pharmacokinetic-pharmacodynamic profile of a novel recombinant human chorionic gonadotropin in healthy women and men of reproductive age
https://ascpt.onlinelibrary.wiley.com/doi/full/10.1111/cts.13037
First published: 13 May 2021...
Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotropic hypogonadism long-term follow-up (1992)
E. VICARI, et al
Summary
The effects of long-term (14-120 months) hCG-treatment of 17 male patients affected by isolated hypogonadotropic...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.